CLK1 and acute myeloid leukemia: Indeed, it was well established that the dual Pim1/2-CLK kinases inhibition promoted very interesting antiproliferative properties against the AML cell line as confirmed by the growth inhibitory activity at a low micromolar concentration, coupled with the nanomolar IC50 values obtained against the enzymes, particularly for the most active compound 44.